189 related articles for article (PubMed ID: 20100839)
1. Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.
Verdoliva A; Bellofiore P; Rivieccio V; Catello S; Colombo M; Albertoni C; Rosi A; Leoni B; Anastasi AM; De Santis R
J Biol Chem; 2010 Mar; 285(12):9090-9. PubMed ID: 20100839
[TBL] [Abstract][Full Text] [Related]
2. AvidinOX for highly efficient tissue-pretargeted radionuclide therapy.
De Santis R; Leoni B; Rosi A; Albertoni C; Forni G; Cojoca R; Iezzi M; Musiani P; Paganelli G; Chinol M; Carminati P
Cancer Biother Radiopharm; 2010 Apr; 25(2):143-8. PubMed ID: 20423226
[TBL] [Abstract][Full Text] [Related]
3. OXavidin for tissue targeting biotinylated therapeutics.
De Santis R; Albertoni C; Rosi A; Leoni B; Petronzelli F; D'Alessio V; Nucera E; Salvatori G; Paganelli G; Verdoliva A; Carminati P; Nuzzolo CA
J Biomed Biotechnol; 2009; 2009():921434. PubMed ID: 20130784
[TBL] [Abstract][Full Text] [Related]
4. Chemical linkage to injected tissues is a distinctive property of oxidized avidin.
De Santis R; Anastasi AM; Pelliccia A; Rosi A; Albertoni C; Verdoliva A; Petronzelli F; D'Alessio V; Serani S; Nuzzolo CA
PLoS One; 2011; 6(6):e21075. PubMed ID: 21701578
[TBL] [Abstract][Full Text] [Related]
5. Characterization of therapeutic protein AvidinOX by an integrated analytical approach.
Giannini G; Alekseeva A; Naggi A; Salvini L; Tei L; De Santis R
Anal Bioanal Chem; 2018 Jan; 410(2):553-564. PubMed ID: 29167933
[TBL] [Abstract][Full Text] [Related]
6. AvidinOX™ for tissue targeted delivery of biotinylated cells.
Nucera E; Nicoletti C; Chiapparino C; Pacello ML; D'Alessio V; Musarò A; De Santis R
Int J Immunopathol Pharmacol; 2012; 25(1):239-46. PubMed ID: 22507336
[TBL] [Abstract][Full Text] [Related]
7. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
Hoya K; Guterman LR; Miskolczi L; Hopkins LN
Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
[TBL] [Abstract][Full Text] [Related]
8. Avidin related protein 2 shows unique structural and functional features among the avidin protein family.
Hytönen VP; Määttä JA; Kidron H; Halling KK; Hörhä J; Kulomaa T; Nyholm TK; Johnson MS; Salminen TA; Kulomaa MS; Airenne TT
BMC Biotechnol; 2005 Oct; 5():28. PubMed ID: 16212654
[TBL] [Abstract][Full Text] [Related]
9. Aromatic side-chain cluster of biotin binding site of avidin allows circular dichroism spectroscopic investigation of its ligand binding properties.
Zsila F
J Mol Recognit; 2011; 24(6):995-1006. PubMed ID: 22038806
[TBL] [Abstract][Full Text] [Related]
10. Novel circular dichroism spectroscopic approach for detection of ligand binding of proteins: avidin as example.
Zsila F
Anal Biochem; 2009 Aug; 391(2):154-6. PubMed ID: 19450538
[TBL] [Abstract][Full Text] [Related]
11. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
Campos SK; Parrott MB; Barry MA
Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
[TBL] [Abstract][Full Text] [Related]
12. Nitroavidin as a ligand for the surface capture and release of biotinylated proteins.
Bolivar JG; Soper SA; McCarley RL
Anal Chem; 2008 Dec; 80(23):9336-42. PubMed ID: 19551994
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the important Tyr-33 residue of chicken avidin: functional and structural consequences.
Marttila AT; Hytönen VP; Laitinen OH; Bayer EA; Wilchek M; Kulomaa MS
Biochem J; 2003 Jan; 369(Pt 2):249-54. PubMed ID: 12358604
[TBL] [Abstract][Full Text] [Related]
14. Preparation of ferritin-avidin conjugates by reductive alkylation for use in electron microscopic cytochemistry.
Bayer EA; Skutelsky E; Wynne D; Wilchek M
J Histochem Cytochem; 1976 Aug; 24(8):933-9. PubMed ID: 182877
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
Schechter B; Silberman R; Arnon R; Wilchek M
Eur J Biochem; 1990 Apr; 189(2):327-31. PubMed ID: 2186907
[TBL] [Abstract][Full Text] [Related]
16. Switchavidin: reversible biotin-avidin-biotin bridges with high affinity and specificity.
Taskinen B; Zauner D; Lehtonen SI; Koskinen M; Thomson C; Kähkönen N; Kukkurainen S; Määttä JA; Ihalainen TO; Kulomaa MS; Gruber HJ; Hytönen VP
Bioconjug Chem; 2014 Dec; 25(12):2233-43. PubMed ID: 25405260
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates.
Salmaso S; Semenzato A; Bersania S; Chinol M; Paganelli G; Caliceti P
Biochim Biophys Acta; 2005 Oct; 1726(1):57-66. PubMed ID: 15964691
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-based detection of glycoproteins on blot transfers using avidin-biotin technology.
Bayer EA; Ben-Hur H; Wilchek M
Anal Biochem; 1987 Feb; 161(1):123-31. PubMed ID: 3034095
[TBL] [Abstract][Full Text] [Related]
19. (Strept)avidin as a template for ligands other than biotin: An overview.
Hytönen VP
Methods Enzymol; 2020; 633():21-28. PubMed ID: 32046847
[TBL] [Abstract][Full Text] [Related]
20. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis.
Rosebrough SF; Hartley DF
J Nucl Med; 1996 Aug; 37(8):1380-4. PubMed ID: 8708779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
